Abstract
Cannabidiol (CBD), a component of Cannabis sativa, has been studied for its therapeutic properties in several medical conditions. Clinical indications include the treatment of refractory epilepsies, anxiety disorders, chronic pain of neuropathic or inflammatory origin, sleep disorders such as insomnia, and neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease. The use of CBD is considered when other therapeutic options fail, in patients intolerant to the adverse effects of conventional medications, or as an adjuvant therapy to enhance the effectiveness of other treatments.
DOI:https://doi.org/10.56238/sevened2024.005-025